Notice of Interim Results & Investor Presentation
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your IXI notes
06 May 2025 IXICO plc (AIM: IXI), a global leader in neuroscience imaging, using its AI-driven platform to help advance drug development in neurological disorders, confirms it will issue unaudited interim results for the six months ended 31 March 2025 on Tuesday 20 May 2025.
Bram Goorden (CEO) and Grant Nash (CFO) will provide a live presentation to all existing and potential shareholders relating to the Interim Results and the Company's progress and ongoing strategy via:
The Investor Meet Company platform on 20 May 2025 at 16:30 BST.
Investors can sign up to Investor Meet Company for free and add to meet IXICO PLC via:
A recording of the results presentation will be made available on the Group's website here: https://ixico.com/investors/company-information/investor-videos/
Giles Balleny / Dan Hodkinson (Corporate Finance) Nigel Birks (Healthcare Specialist Sales) Harriet Ward (Corporate Broking) Michael F Johnson (Sales)
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.